Institute of Data
  • Learn Practical AI Skills
  • Find Jobs
  • Career Consultation
  • Job Alerts
  • Post a Job
  • Employers
  • Sign in
  • Sign up
  • Learn Practical AI Skills
  • Find Jobs
  • Career Consultation
  • Job Alerts
  • Post a Job
  • Employers

2 digital strategist practice jobs found in Conshohocken, PA

Refine Search
Current Search
Conshohocken digital strategist practice Pennsylvania
Refine by Specialisation
Security  (1)
Refine by Job Type
Full time  (2)
Refine by Country
United States  (2)
Ce
Full time
 
Sr Dir - Information Security
Cencora Conshohocken, PA, USA
Our team members are at the heart of everything we do. At Cencora, we are united in our responsibility to create healthier futures, and every person here is essential to us being able to deliver on that purpose. If you want to make a difference at the center of health, come join our innovative company and help us improve the lives of people and animals everywhere. Apply today! Job Details JOB PROFILE SUMMARY The Senior Director, Customer and Cloud IAM is responsible for building strong partnerships with business units, technology teams, corporate support functions, and the user community to protect the corporate brand, data, and digital assets. This role leads the design, implementation, operation, and continuous improvement of an enterprise-wide identity and access management framework covering both customer identity (CIAM) and cloud-native IAM capabilities. As a senior leader within...

Jan 08, 2026
MP
Full time
 
Senior Director, Global Scientific Content
Madrigal Pharmaceuticals Conshohocken, PA, USA
Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To support our...

Dec 27, 2025
  • Home
  • Learn Practical AI Skills
  • Contact
  • About Us
  • Terms & Conditions
  • Industry Training
  • United States
  • Australia
  • Singapore
  • New Zealand
  • Industry Jobs
  • Find Jobs
  • Create Resume
  • Sign in
  • Career Consultation
  • Facebook
  • LinkedIn
© Institute of Data. All rights reserved.